Firalis is a startup based in France, most recent round Series-c-plus, 1 tracked investor.
Firalis is a startup based in France. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Firalis is a biotechnology company focused on the discovery, development, and qualification of biomarkers for diagnostic and therapeutic purposes. The company offers biomarker-based diagnostic, prognostic, and theranostic tools, including research-use-only kits and in vitro diagnostic tools, along with biomarker-related contract research organization (CRO) services.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.